user

Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine: Comment

被引：0
|
作者：
Daungsupawong, Hinpetch [2 ]
Wiwanitkit, Viroj [1 ]
机构：
[1] Saveetha Univ, Saveetha Dent Coll & Hosp, Saveetha Inst Med & Tech Sci, Dept Res Analyt, Chennai, India
[2] Lak52 Phonhong, Viangchan, Laos
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2024年 / 20卷 / 01期
关键词：
HPV; vaccine; surveillance;
D O I：
10.1080/21645515.2024.2306032
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Post-marketing surveillance for the safety of the 9-valent human papillomavirus vaccine: a retrospective real-world study in China
    Meng, Ruogu
    Ma, Rui
    Wang, Jianmei
    Liu, Peipei
    Liu, Zuoxiang
    He, Bingjie
    Liu, Zhike
    Yang, Yu
    Zhan, Siyan
    [J]. EXPERT REVIEW OF VACCINES, 2023, 22 (01) : 696 - 703
  • [2] Post-marketing surveillance for the safety of the 9-valent human papillomavirus vaccine in China: A retrospective real-world study
    Meng, Ruogu
    Ma, Rui
    Wang, Jianmei
    Liu, Peipei
    Liu, Zuoxiang
    He, Bingjie
    Liu, Zhike
    Yang, Yu
    Zhan, Siyan
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 598 - 598
  • [3] Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine in individuals aged 16-26 years in Chongqing, China
    Zhang, Yuan-yuan
    Xu, Jia-Wei
    Liu, Yang
    Qiu, Wei
    Bai, Pei-Ning
    Zeng, Yi
    Wang, Qing
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
  • [4] Extended surveillance to assess safety of 9-valent human papillomavirus vaccine
    Sundaram, Maria E.
    Kieke, Burney A.
    Hanson, Kayla E.
    Belongia, Edward A.
    Weintraub, Eric S.
    Daley, Matthew F.
    Hechter, Rulin C.
    Klein, Nicola. P.
    Lewis, Edwin. M.
    Naleway, Allison L.
    Nelson, Jennifer C.
    Donahue, James G.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 18 (07)
  • [5] Safety of the 9-Valent Human Papillomavirus Vaccine
    Shimabukuro, Tom T.
    Su, John R.
    Marquez, Paige L.
    Mba-Jonas, Adamma
    Arana, Jorge E.
    Cano, Maria, V
    [J]. PEDIATRICS, 2019, 144 (06)
  • [6] A Broad Safety Assessment of the 9-Valent Human Papillomavirus Vaccine
    Yih, W. Katherine
    Kulldorff, Martin
    Dashevsky, Inna
    Maro, Judith C.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2021, 190 (07) : 1253 - 1259
  • [7] A broad safety assessment of the 9-valent human papillomavirus vaccine
    Yih, Katherine
    Kulldorff, Martin
    Dashevsky, Inna
    Maro, Judith
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 621 - 621
  • [8] Near Real-Time Surveillance to Assess the Safety of the 9-Valent Human Papillomavirus Vaccine
    Donahue, James G.
    Kieke, Burney A.
    Lewis, Edwin M.
    Weintraub, Eric S.
    Hanson, Kayla E.
    McClure, David L.
    Vickers, Elizabeth R.
    Gee, Julianne
    Daley, Matthew F.
    DeStefano, Frank
    Hechter, Rulin C.
    Jackson, Lisa A.
    Klein, Nicola P.
    Naleway, Allison L.
    Nelson, Jennifer C.
    Belongia, Edward A.
    [J]. PEDIATRICS, 2019, 144 (06)
  • [9] Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study
    Amend, Kandace L.
    Turnbull, Bruce
    Zhou, Li
    Marks, Morgan A.
    Velicer, Christine
    Saddier, Patricia
    Seeger, John D.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [10] Safety of 9-valent human papillomavirus vaccine administered to males and females in routine use
    Hansen, John
    Yee, Arnold
    Lewis, Ned
    Li, Se
    Velicer, Christine
    Saddier, Patricia
    Klein, Nicola P.
    [J]. VACCINE, 2023, 41 (11) : 1819 - 1825
12345